Drug Topics January 2021

Apart from COVID-19, there are several other industry trends taking root that will likely have a transformative effect on the profession in years to come.

Over-the-counter product selection for patients with diabetes.

“We have met the enemy, and they are ours!”

Pharmacists can adapt their skills to keep up with an evolving profession.

On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).

There are a variety of promising and unique medications in different therapeutic areas expected for approval in 2021.

Several key regulatory changes made over the past year affect health-system pharmacists.

Tanvee Thakur, PhD, BPharm, recently completed a project focused on enhancing transparent opioid education.

Elizabeth Dragatsi, RPh, BCPS, worked on 2 projects integrating community pharmacists into contingency management and opioid education.

How will a change in administration, a vaccine for COVID-19, and other factors change the industry in the year ahead?

Pharmacists can prepare themselves to address patients’ questions and concerns about the COVID-19 vaccines.

In a virtual session held during the ASHP Midyear 2020 Clinical Meeting & Exhibition, experts discussed updates in asthma management, including new data and upcoming guideline changes that will impact pharmacy practice.